In addition to the lymphoid lineage markers including CD3, CD4, CD8, CD20, CD45, CD56, and FOXP3, we also examined myeloid lineage markers such as CD14, CD68, CD34 to accurately identify the specific cell types within the tumor microenvironment of YTMA-76. This evidence concerns the gene NCAM1 and neoplasm.